Case of Raynaud Syndrome after the Use of Methimazole
Journal of Rheumatic Diseases
;
: 203-206, 2018.
Artigo
em Inglês
| WPRIM
| ID: wpr-715822
ABSTRACT
Raynaud syndrome is a medical condition that causes pain, numbness, and changes in skin color at the distal extremities. Raynaud syndrome can be subdivided into primary Raynaud's and secondary Raynaud's. The former is diagnosed when the cause is unknown and the latter is caused by an underlying condition, such as connective tissue diseases, injury, smoking, or certain medications. Both cancer chemotherapy and β-blockers are relatively common causes of Raynaud syndrome but there are no reports of its association with methimazole administration. The authors encountered a 43-year old woman with hyperthyroidism who developed digital ulcers associated with Raynaud syndrome after a methimazole treatment. Her digital ulcers and Raynaud syndrome were improved after methimazole was replaced with propylthiouracil and conventional therapy. This paper reports this case along with a review of the relevant literature.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Propiltiouracila
/
Fumaça
/
Úlcera
/
Pigmentação da Pele
/
Fumar
/
Doenças do Tecido Conjuntivo
/
Tratamento Farmacológico
/
Extremidades
/
Hipertireoidismo
/
Hipestesia
Limite:
Feminino
/
Humanos
Idioma:
Inglês
Revista:
Journal of Rheumatic Diseases
Ano de publicação:
2018
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS